Long Term Safety Study of Ecopipam Tablets in Children, Adolescents and Adults with Tourette s Diso
The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to [>=] 6 and less than [=12 and =18 years of age) with Tourette's Syndrome (TS).
- Investigator
- Irene A Malaty
- Status
- Accepting Candidates
- Ages
- 6 Years - N/A
- Sexes
- All
Abbvie Real World
Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. The…
- Investigator
- Irene A Malaty
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
D1AMOND
This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by…
- Investigator
- Irene A Malaty
- Status
- Accepting Candidates
- Ages
- 6 Years - N/A
- Sexes
- All